IL6 and esophageal squamous cell carcinoma: To further evaluate the role of activated fibroblast-secreted IL-6 in cisplatin resistance, ESCC cells were cultured in CM/activated fibroblast in the presence or absence of IL-6 receptor neutralizing antibody (tocilizumab).